Humanetics Corporation

EDINA, MN 55435

SBIR Award Summary

Total Number of Awards 5
Total Value of Awards $1.42MM
First Award Date 09/02/09
Most Recent Award Date 07/01/17

Key Personnel

Last Name Name Awards Contact
Zenk John L. Zenk 2
KAYTOR MICHAEL D KAYTOR 3
VUJASKOVIC ZELJKO VUJASKOVIC 1
JACKSON ISABEL LAUREN JACKSON 2

5 Awards Won

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic: PA-15-065
Budget: 07/01/17 - 06/30/18

Project Summary A significant need exists for effective medical countermeasures for radiation-induced pneumonitis and pulmonary fibrosis associated with the delayed effects of acute radiation exposure. Of great importance are countermeasures that can be distributed for use without medical supervision, making orally effective countermeasures of h...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic: PA-15-065
Budget: 07/01/16 - 06/30/17

Project SummaryA significant need exists for effective medical countermeasures for radiation-induced pneumonitis andpulmonary fibrosis associated with the delayed effects of acute radiation exposure. Of greatimportance are countermeasures that can be distributed for use without medical supervision, makingorally effective countermeasures of high ...

Phase 1 STTR

Agency: Department of Health & Human Services
Topic: PA-13-235
Budget: 07/01/14 - 06/30/15

DESCRIPTION (provided by applicant): The aim of this proposal is to evaluate BIO 300 as an effective therapy to prevent and/or mitigate the erectile dysfunction (ED) that is commonly observed following radiotherapy (RT) for prostate cancer. Prostate cancer is the most common cancer among men in the United States. Approximately half of prosta...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic: PA-06-134
Budget: 09/01/10 - 08/31/12

DESCRIPTION (provided by applicant): The detonation by a terrorist of an improvised nuclear device would expose hundreds of thousands of citizens to acute radiation syndrome (ARS), which untreated leads to death. There are currently no approved drugs available for the prevention or treatment of ARS. Effective drugs with acceptable safety profile...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic: PA-06-134
Budget: 09/02/09 - 08/31/10

DESCRIPTION (provided by applicant): The detonation by a terrorist of an improvised nuclear device would expose hundreds of thousands of citizens to acute radiation syndrome (ARS), which untreated leads to death. There are currently no approved drugs available for the prevention or treatment of ARS. Effective drugs with acceptable safety profile...